Navigation Links
AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain

The Company is considering whether it would be necessary or advisable to study a similar lower dose of quinidine in a second Phase III trial being planned for DPN pain.

About AVANIR

AVANIR Pharmaceuticals is focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. AVANIR's products and product candidates address therapeutic markets that include the central nervous system, cardiovascular disorders, inflammation and infectious diseases. AVANIR currently markets FazaClo(R), the only orally-disintegrating formulation of clozapine for the management of severely ill schizophrenic patients who fail to respond adequately to standard drug treatments for schizophrenia. FazaClo is also indicated for reducing the risk of suicidal behavior in patients with schizophrenia or schizoaffective disorder. For full prescribing information and important safety information regarding FazaClo, please visit www.fazaclo.com. AVANIR's lead product candidate for the treatment of involuntary emotional expression disorder (IEED), Zenvia, is the subject of an approvable letter from the FDA. Additionally, AVANIR recently completed a Phase III clinical trial with Zenvia in patients with diabetic peripheral neuropathic (DPN) pain where all primary endpoints were met. AVANIR has an ongoing development program with Novartis International Pharmaceutical Ltd. for the treatment of inflammatory disease. The Company's first commercialized product, Abreva(R), is marketed in North America by GlaxoSmithKline Consumer Healthcare and is the leading over-the-counter product for the treatment of cold sores. Further information about AVANIR can be found at www.avanir.com.

Forward Looking Statement

Statements in this press release that are not historical facts, including statements that are preceded by, followed by, or that include such words as "estimate," "intend," "anticipate," "believe," "plan," "goal," "expect," or simila
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at Second International Congress on Neuropathic Pain
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:5/21/2008)... Leading Urologist Presents OrBIT Study Result... with Pharmaceutical Therapy at the 2008 American ...ing, MINNEAPOLIS, May 21 /...mpany that develops, manufactures and markets,inno...oiding dysfunction,today highlighted results from...
(Date:5/21/2008)... HILDEN, Germany, May 21 /PRNewswire-FirstCal...h HPV Test as Front-line,Screen, Long-term data f... of,Cancer show that women screened only with a hu...ly to develop moderate to severe cervical disease ...entional cytology (the Pap,"smear"). The research ...
(Date:5/20/2008)... Sahajanand Medical Technologies received posit...uting stents, Infinnium and Supralimus. The result... 2008-Barcelona., SURAT, India, May 20 /PRNewswir...MT), Surat, India, leading developer and manufactu...results of the prospective,randomized nine months...
(Date:5/20/2008)... Statistically Significant Reduction of IBS Pai... Effect Observed, SAN DIEGO, May 20 /PRNewswir...the results of a recent Phase 2b study of its oral... demonstrated statistically significant,results in...Asimadoline,produced significant improvement in di...
Breaking Medicine Technology:Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System 2Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System 3Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 2Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 3Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 4Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 2Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 3Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 2Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 3Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 4Body identification by facial reconstruction will cost less time and money 14156 1Body identification by facial reconstruction will cost less time and money 14156 2Caring com Joins Entrepreneurs Foundation as 200th Member 14153 1Caring com Joins Entrepreneurs Foundation as 200th Member 14153 2Sutter Regional Medical Foundation Receives ACR Accreditation 14151 1Sutter Regional Medical Foundation Receives ACR Accreditation 14151 2CardioDynamics Board of Directors Proposes Reverse Split 1 3A7 of Companys Shares 14148 1CardioDynamics Board of Directors Proposes Reverse Split 1 3A7 of Companys Shares 14148 2
... - A new analysis,has found that many alcohol trea...tly omit women and African-Americans from,particip...researcher who led the effort said the findings sh...bility criteria can have,unintended, negative cons...0 alcohol treatment,patients, Keith Humphreys, PhD...
...r said today that,results showing potential across...id, liver, non-small cell lung (NSCLC), colorectal...advanced kidney,cancer - will be presented next we...SCO) annual meeting in Chicago., "Each person with... critical that physicians have the flexibility of ...
Other Medicine Technology:Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 2Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 3New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 2New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 3New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 4New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 5
(Date:5/22/2008)...ewswire/ -- Many baby boomers,incorrectly believe ...to a,new survey conducted by Harris Interactive(R)...IP). Most say that disability insurance is importa...ey do not have any disability,income protection., ...830/AHIPLOGO ), "Baby boomers recognize the valu...
(Date:5/22/2008)...nt for Adult Acne Sufferers, LOS ANGELES, May 22 ...ewed as a teenage "rite of passage," results from ...ow that acne is a problem that also,commonly affec...ly impact,many aspects of a person,s life -- profe...sic lack of knowledge may be preventing or hinderi...
(Date:5/22/2008)...Fat Compartment Essential to Facial,Rejuvenation, ...IGHTS, Ill., May 22 /PRNewswire-USNewswire/ - Not ...entral to the American concept of,beauty. A study ...he,official medical journal of the American Societ...t compartment located within the cheek is vital,to...
(Date:5/22/2008)... Of Its Summer-Long Harley-Davidson ...EE, May 22 /PRNewswire/ -- Miller Brewing Company ...ociation (MDA) for every Miller Lite,bottle cap co...brand,s,"Better. Bolder. Summer" promotion. Miller...beer sponsor of this summer,s Harley-Davidson 105t...
Breaking Medicine News(10 mins):Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 2Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 3Health News:Acne - Not Just a Teen Issue 2Health News:Acne - Not Just a Teen Issue 3Health News:Acne - Not Just a Teen Issue 4Health News:Acne - Not Just a Teen Issue 5Health News:Acne - Not Just a Teen Issue 6Health News:Key to Angelina-Like Cheeks? Add Volume to Deep Fat Compartment 2Health News:Miller Lite Bottle Caps Equal Cash for MDA This Summer 2Health News:Miller Lite Bottle Caps Equal Cash for MDA This Summer 3
...ients may one day have the option of having one bl...ries of up to 25 sessions afterwards, researchers ...therapy could be cheaper and easier for women and ...er for patients living in remote areas or in the d...
...as shown that new compounds developed for preventi...mal studies, and may require only one dose to be e...ultimeric zanamivir, are based on the existing flu....S. Food and Drug administration approved in 1999 ...
...n cells of oral leukoplakia, specifically the numb... of oral carcinoma, according to study.// 123 pati...8.5 years, found that oral leukoplakia with the no...o develop into cancer. Of the 103 patients with le...
...archers, a drug commonly used for short-term treat...tients may cause dangerously low blood pressure an...hat the drug, milrinone, should be reserved for pa...ication, said Dr. Mihai Gheorghiade of Northwester...
Other Medicine News:Health News:Heart Drug has grave side effects 2
The latest addition to Aerotels Transtelephonic ECG product line, HeartOne™ is a unique miniaturized single-lead, 4-event recorder/transmitter designed for transmission on cellular (GSM) and an
...PowerPath is IMPACs comprehensive information syst...ogy laboratories to integrate and streamline their...h a single, intuitive software solution. Thousands...stitutions have proven PowerPaths unique "case-cen...
...PowerPath is IMPACs comprehensive information syst...ogy laboratories to integrate and streamline their...h a single, intuitive software solution. Thousands...stitutions have proven PowerPaths unique "case-cen...
The most compact revolutionary innovation in hematology. 26 paramaters with 5 part DIFF.
Medicine Products: